Structural and mechanistic basis for extended-spectrum drug-resistance mutations in altering the specificity of TEM, CTX-M, and KPC β-lactamases

Frontiers in Molecular Biosciences

Volumn 5, Issue FEB, 2018, Pages

  Palzkill, Timothy ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Antibiotic resistance; Enzyme mechanism; Enzyme structure; Protein evolution; lactam antibiotics; lactamase

Indexed keywords

EID: 85042730453     PISSN: None     EISSN: 2296889X     Source Type: Journal    
DOI: 10.3389/fmolb.2018.00016     Document Type: Review

References (96)

1. Adachi, H., Ohta, T., and Matsuzawa, H. (1991). Site-directed mutants, at position 166, of RTEM-1 beta-lactamase that form a stable acyl-enzyme intermediate with penicillin. J. Biol. Chem. 266, 3186-3191
2. Adamski, C. J., Cardenas, A. M., Brown, N. G., Horton, L. B., Sankaran, B., Prasad, B. V., et al. (2015). Molecular basis for the catalytic specificity of the CTX-M extended spectrum β-lactamases. Biochemistry 54, 447-457. doi: 10.1021/bi501195g
3. Ambler, R. P., Coulson, F. W., Frere, J. M., Ghuysen, J. M., Joris, B., Forsman, M., et al. (1991). A standard numbering scheme for the class A β-lactamases. Biochem. J. 276, 269-272. doi: 10.1042/bj2760269
4. Ambler, R. P. (1980). The structure of beta-lactamases. Phil. Trans. R. Soc. Lond. B Biol. Sci. 289, 321-331. doi: 10.1098/rstb.1980.0049
5. Bar-Even, A., Milo, R., Noor, E., and Tawik, D. S. (2015). The moderately efficient enzyme: futile encounters and enzyme floppiness. Biochemistry 54, 4969-4977. doi: 10.1021/acs.biochem.5b00621
6. Bershtein, S., Goldin, K., and Tawfik, D. S. (2008). Intense neutral drifts yield robust and evolvable consensus proteins. J. Mol. Biol. 379, 1029-1044. doi: 10.1016/j.jmb.2008.04.024
7. Bloom, J. D., and Arnold, F. H. (2009). In the light of directed evolution: pathways of adaptive protein evolution. Proc. Natl. Acad. Sci. U.S.A. 106(Suppl. 1), 9995-10000. doi: 10.1073/pnas.0901522106
8. Bonnet, R., Dutour, C., Sampaio, J. L. M., Chanal, C., Sirot, D., Labia, R., et al. (2001). Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-Gly. Antimicrob. Agents Chemother. 45, 2269-2275. doi: 10.1128/AAC.45.8.2269-2275.2001
9. Bonnet, R., Recule, C., Baraduc, R., Chanal, C., Sirot, D., De Champs, C., et al. (2003). Effect of D240G substitution in a novel ESBL CTX-M-27. J. Antimicrob. Chemother. 52, 29-35. doi: 10.1093/jac/dkg256
10. Bonnet, R. (2004). Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48, 1-14. doi: 10.1128/AAC.48.1.1-14.2004
11. Bonomo, R. A. (2017). β-lactamases: a focus on current challenges. Cold Spring Harb. Perspect. Med. 7:a025239. doi: 10.1101/cshperspect.a025239
12. Bowman, G. R., and Geissler, P. L. (2012). Equilibrium fluctuations of a single folded protein reveal a multitude of potential cryptic allosteric sites. Proc. Natl. Acad. Sci. U.S.A. 109, 11681-11686. doi: 10.1073/pnas.1209309109
13. Bowman, G. R., Bolin, E. R., Hart, K. M., Maguire, B. C., and Marqusee, S. (2015). Discovery of multiple hidden allosteric sites by combining Markov state models and experiments. Proc. Natl. Acad. Sci. U.S.A. 112, 2734-2739. doi: 10.1073/pnas.1417811112
14. Brown, N. G., Pennington, J. M., Huang, W., Ayvaz, T., and Palzkill, T. (2010). Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases. J. Mol. Biol. 404, 832-846. doi: 10.1016/j.jmb.2010.10.008
15. Bush, K., and Fisher, J. F. (2011). Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from Gram-negative bacteria. Ann. Rev. Microbiol. 65, 455-478. doi: 10.1146/annurev-micro-090110-102911
16. Bush, K. (2002). The impact of β-lactamases on the development of novel antimicrobial agents. Curr. Opin. Invest. Drugs 3, 1284-1290
17. Cantón, R., González-Alba, J. M., and Galán, J. C. (2012). CTX-M enzymes: origin and diffusion. Front. Microbiol. 3:110. doi: 10.3389/fmicb.2012.00110
18. Cantu, C. III., and Palzkill, T. (1998). The role of residue 238 of TEM-1 β-lactamase in the hydrolysis of extended-spectrum antibiotics. J. Biol. Chem. 273, 26603-26609. doi: 10.1074/jbc.273.41.26603
19. Cantu, C. III., Huang, W., and Palzkill, T. (1996). Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 β-lactamase with altered substrate specificity for aztreonam and ceftazidime. J. Biol. Chem. 271, 22538-22545. doi: 10.1074/jbc.271.37.22538
20. Cantu, C. III., Huang, W., and Palzkill, T. (1997). Cephalosporin substrate specificity determinants of TEM-1 β-lactamase. J. Biol. Chem. 272, 29144-29150. doi: 10.1074/jbc.272.46.29144
21. Cartelle, M., del Mar Tomas, M., Molina, F., Moure, R., Villanueva, R., and Bou, G. (2004). High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. Antimicrob. Agents Chemother. 48, 2308-2313. doi: 10.1128/AAC.48.6.2308-2313.2004
22. Chanal-Claris, C., Sirot, J., Bret, L., Chatron, P., Labia, R., and Sirot, J. (1997). Novel extended-spectrum TEM-type β-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin. Antimicrob. Agents Chemother. 41, 715-716
23. Chen, Y., Delmas, J., Sirot, J., Shoichet, B., and Bonnet, R. (2005). Atomic resolution structures of CTX-M beta-lactamases: extended spectrum activities from increased mobility and decreased stability. J. Mol. Biol. 348, 349-362. doi: 10.1016/j.jmb.2005.02.010
24. Christensen, H., Martin, M., and Waley, G. (1990). β-Lactamases as fully efficient enzymes. a. Biochem. J. 266, 853-861
25. Damblon, C., Raquet, X., Lian, L. Y., Lamotte-Brasseur, J., Fonze, E., Charlier, P., et al. (1996). The catalytic mechanism of β-lactamases: NMR titration of an active-site lysine residue of the TEM-1 enzyme. Proc. Natl. Acad. Sci. U.S.A. 93, 1747-1752. doi: 10.1073/pnas.93.5.1747
26. D'Andrea, M. M., Arena, F., Pallecchi, L., and Rossolini, G. M. (2013). CTX-M-type β-lactamases: a succesful story of antibiotic resistance. Int. J. Med. Microbiol. 303, 305-317. doi: 10.1016/j.ijmm.2013.02.008
27. Datta, N., and Kontomichalou, P. (1965). Penicillinase synthesis controlled by infectious R factors in Enterobacteriacea. Nature 208, 239-241. doi: 10.1038/208239a0
28. de Visser, J. A., and Krug, J. (2014). Empirical fitness landscapes and the predictability of evolution. Nat. Rev. Genet. 15, 480-490. doi: 10.1038/nrg3744
29. Delaire, M., Lenfant, F., Labia, R., and Masson, J. M. (1991). Site-directed mutagenesis on TEM-1 β-lactamase: role of Glu166 in catalysis and substrate binding. Protein Eng. 4, 805-810. doi: 10.1093/protein/4.7.805
30. Dellus-Gur, E., Elias, M., Caselli, E., Prati, F., Salverda, M. L. M., De Visser, J. A. G. M., et al. (2015). Negative epistasis and evolvability in TEM-1 β-lactamase-the thin line between an enzyme's conformational freedom and disorder. J. Mol. Biol. 427, 2396-2409. doi: 10.1016/j.jmb.2015.05.011
31. Delmas, J., Chen, Y., Prati, F., Robin, F., Shoichet, B. K., and Bonnet, R. (2008). Structure and dynamics of CTX-M enzymes reveal insights into substrate accommodation by extended-spectrum β-lactamases. J. Mol. Biol. 375, 192-201. doi: 10.1016/j.jmb.2007.10.026
32. Delmas, J., Leyssene, D., Dubois, D., Birck, C., Vazeille, E., Robin, F., et al. (2010). Structural insights into substrate recognition and product expulsion in CTX-M enzymes. J. Mol. Biol. 400, 108-120. doi: 10.1016/j.jmb.2010.04.062
33. Deng, Z., Huang, W., Bakkalbasi, E., Brown, N. G., Adamski, C. J., Rice, K., et al. (2012). Deep sequencing of systematic combinatorial libraries reveals beta-lactamase sequence constraints at high resolution. J. Mol. Biol. 424, 150-167. doi: 10.1016/j.jmb.2012.09.014
34. Docquier, J. D., Benvenuti, M., Calderone, V., Rossolini, G. M., and Gangani, S. (2011). Structure of the extended-spectrum β-lactamase TEM-72 inhibited by citrate. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 67, 303-306. doi: 10.1107/S1744309110054680
35. Drawz, S. M., and Bonomo, R. A. (2010). Three decades of beta-lactamase inhibitors. Clin. Microbiol. Rev. 23, 160-201. doi: 10.1128/CMR.00037-09
36. Escobar, W. A., Tan, A. K., and Fink, A. L. (1991). Site-directed mutagenesis of β-lactamase leading to accumulation of an acyl-enzyme intermediate. Biochemistry 30, 10783-10787. doi: 10.1021/bi00108a025
37. Farzaneh, S., Chaibi, E. B., Peduzzi, J., Barthelemy, M., Labia, R., Blazquez, J., et al. (1996). Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamase. Antimicrob. Agents Chemother. 40, 2434-2436
38. Fisher, J. F., and Mobashery, S. (2009). Three decades of the class A beta-lactamase acyl-enzyme. Curr. Prot. Pept. Sci. 10, 401-407. doi: 10.2174/138920309789351967
39. Fisher, J. F., Meroueh, S. O., and Mobashery, S. (2005). Bacterial resistance to beta-lactam antibiotics: compelling opportusism, compelling opportunity. Chem. Rev. 105, 395-424. doi: 10.1021/cr030102i
40. Fonseca, F., Chudyk, E. I., Van Der Kamp, M. W., Correia, A., Mulholland, A. J., and Spencer, J. (2012). The basis for carbapenem hydrolysis by class A β-lactamases: a combined investigation using crystallography and simulations. J. Amer. Chem. Soc. 134, 18275-18285. doi: 10.1021/ja304460j
41. Galleni, M., and Frere, J. M. (2007). "Kinetics of β-lactamases and penicillin-binding proteins, "in Enzyme-Mediated Resistance to Antibiotics: Mechanisms, Dissemination, and Prospects for Inhibition, eds R. A. Bonomo and M. E. Tolmasky (Washington, DC: ASM Press), 67-79
42. Giakkoupi, P., Tzelepi, E., Tassios, P. T., Legakis, N. J., and Tzouvelekis, L. S. (2000). Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation. J. Antimicrob. Chemother. 45, 101-104. doi: 10.1093/jac/45.1.101
43. Gniadkowski, M. (2008). Evolution of extended-spectrum β-lactamases by mutation. Clin. Microb. Infect. 14, 11-32. doi: 10.1111/j.1469-0691.2007.01854.x
44. Hall, A., and Knowles, J. R. (1976). Directed selective pressure on a beta-lactamase to analyse molecular changes involved in the development of enzyme function. Nature 264, 803-804. doi: 10.1038/264803a0
45. Hart, K. M., Ho, C. M., Dutta, S., Gross, M. L., and Bowman, G. R. (2016). Modelling proteins' hidden conformations to predict antibiotic resistance. Nat. Commun. 7:12965. doi: 10.1038/ncomms12965
46. Healy, W. J., Labgold, M. R., and Richards, J. H. (1989). Substrate preferences in class A β-lactamases: preference for penams vs. cephems. The role of residue 237. Proteins Struct. Func. Genet. 6, 275-283. doi: 10.1002/prot.340060310
47. Hedstrom, L. (2002). Serine protease mechanism and specificity. Chem. Rev. 102, 4501-4523. doi: 10.1021/cr000033x
48. Herzberg, O., and Moult, J. (1987). Bacterial resistance to beta-lactam antibiotics: crystal structure of beta-lactamase from Staphylococcus aureus PC1 at 2.5 Å resolution. Science 236, 694-701. doi: 10.1126/science.3107125
49. Horn, J. R., and Shoichet, B. K. (2004). Allosteric inhibition through core disruption. J. Mol. Biol. 336, 1283-1291. doi: 10.1016/j.jmb.2003.12.068
50. Huang, W., and Palzkill, T. (1997). A natural polymorphism in β-lactamase is a global suppressor. Proc. Natl. Acad. Sci. U.S.A. 94, 8801-8806. doi: 10.1073/pnas.94.16.8801
51. Huletsky, A., Knox, J. R., and Levesque, R. C. (1993). Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type β-lactamases probed by site-directed mutagenesis and three-dimensional modeling. J. Biol. Chem. 268, 3690-3697
52. Ishii, Y., Galleni, M., Ma, L., Frere, J. M., and Yamaguchi, K. (2007). Biochemical characterisation of the CTX-M-14 β-lactamase. Int. J. Antimicrob. Agents 29, 159-164. doi: 10.1016/j.ijantimicag.2006.09.005
53. Jorgensen, W. L., and Gao, J. (1988). Cis-trans energy difference for the peptide bond in the gas phase and in aqueous solution. J. Amer. Chem. Soc. 110, 4212-4216. doi: 10.1021/ja00221a020
54. Kather, I., Jakob, R. P., Dobbek, H., and Schmid, F. X. (2008). Increased folding stability of TEM-1 beta-lactamase by in vitro selection. J. Mol. Biol. 383, 238-251. doi: 10.1016/j.jmb.2008.07.082
55. Kimura, S., Ishiguro, M., Ishii, Y., Alba, J., and Yamaguchi, K. (2004). Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis. Antimicrob. Agents Chemother. 48, 1454-1460. doi: 10.1128/AAC.48.5.1454-1460.2004
56. Knies, J. L., Cai, F., and Weinreich, D. M. (2017). Enzyme efficiency but not thermostability drives cefotaxime resistance evolution in TEM-1 β-lactamase. Mol. Biol. Evol. 34, 1040-1054. doi: 10.1093/molbev/msx053
57. Levitt, P. S., Papp-Wallace, K. M., Taracila, M. A., Hujer, A. M., Winkler, M. L., Smith, K. M., et al. (2012). Exploring the role of a conserved class A residue in the W-loop of KPC-2 β-lactamase. J. Biol. Chem. 287, 31783-31793. doi: 10.1074/jbc. M112.348540
58. Livermore, D. M. (2006). The β-lactamase threat in enterobacteriaceae, pseudomonas and acinetobacter. Trends Microbiol. 14, 413-420. doi: 10.1016/j.tim.2006.07.008
59. Lovering, A. L., Safadi, S. S., and Strynadka, N. C. (2012). Structural perspective of peptidoglycan biosynthesis and assembly. Ann. Rev. Biochem. 2012, 451-478. doi: 10.1146/annurev-biochem-061809-112742
60. Marciano, D. C., Pennington, J. M., Wang, X., Wang, J., Chen, Y., Thomas, V. L., et al. (2008). Genetic and structural characterization of an L201P global suppressor substitution in TEM-1 beta-lactamase. J. Mol. Biol. 384, 151-164. doi: 10.1016/j.jmb.2008.09.009
61. Mehta, S. C., Rice, K., and Palzkill, T. (2015). Natural variants of the KPC-2 carbapenemase have evolved increased catalytic efficiency for ceftazidime hydrolysis at the cost of enzyme stability. PLoS Pathog. 11:e1004949. doi: 10.1371/journal.ppat.1004949
62. Meroueh, S. O., Fisher, J. F., Schlegel, H. B., and Mobashery, S. (2005). Ab initio QM/MM study of class A β-lactamase acylation: dual participation of Glu166 and Lys73 in concerted base promotion of Ser70. J. Amer. Chem. Soc. 127, 15397-15407. doi: 10.1021/ja051592u
63. Minasov, G., Wang, X., and Shoichet, B. K. (2002). An ultrahigh resolution structure of TEM-1 beta-lactamase suggests a role for Glu166 as the general base in acylation. J. Am. Chem. Soc. 124, 5333-5340. doi: 10.1021/ja0259640
64. Naas, T., Dortet, L., and Iorga, B. I. (2016). Structural and functional aspects of class A carbapenemases. Curr. Drug Targets 17, 1006-1028. doi: 10.2174/1389450117666160310144501
65. Nordmann, P., Cuzon, G., and Naas, T. (2009). The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9, 228-236. doi: 10.1016/S1473-3099(09)70054-4
66. Orencia, M. C., Yoon, J. S., Ness, J. E., Stemmer, W. P. C., and Stevens, R. C. (2001). Predicting the emergence of antibiotic resistance by directed evolution and structural analysis. Nat. Struc. Biol. 8, 238-242. doi: 10.1038/84981
67. Palzkill, T. (2013). Metallo-β-lactamase structure and function. Ann. N.Y. Acad. Sci. 1277, 91-104. doi: 10.1111/j.1749-6632.2012.06796.x
68. Patel, M. P., Fryszcyn, B. G., and Palzkill, T. (2015). Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX-M β-lactamases. Antimicrob. Agents Chemother. 59, 6741-6748. doi: 10.1128/AAC.00618-15
69. Patel, M. P., Hu, L., Stojanoski, V., Sankaran, B., Prasad, B. V., and Palzkill, T. (2017). The drug-resistant variant P167S expands the substrate profile of CTX-M β-lactamases for oxyimino-cephalosporin antibiotics by enlarging the active site upon acylation. Biochemistry 56, 3443-3453. doi: 10.1021/acs.biochem.7b00176
70. Pendleton, J. N., Gorman, S. P., and Gilmore, B. F. (2013). Clinical relevance of the ESKAPE pathogens. Expert Rev. Anti. Infect. Ther. 11, 297-308. doi: 10.1586/eri.13.12
71. Petit, A., Maveyraud, L., Lenfant, F., Samama, J. P., Labia, R., and Masson, J. M. (1995). Multiple substitutions at position 104 of β-lactamase TEM-1: assessing the role of this residue in substrate specificity. Biochem. J. 305, 33-40. doi: 10.1042/bj3050033
72. Petrosino, J., Cantu Iii, C., and Palzkill, T. (1998). β-lactamases: protein evolution in real time. Trends Microbiol. 6, 323-327. doi: 10.1016/S0966-842X(98)01317-1
73. Philippon, A., Slama, P., Deny, P., and Labia, R. (2016). A structure-based classification of class A β-lactamases, a broadly diverse family of enzymes. Clin. Microb. Rev. 29, 29-57. doi: 10.1128/CMR.00019-15
74. Pimenta, A. C., Fernandes, R., and Moreira, I. S. (2014). Evolution of drug resistance: insight on TEM-1 β-lactamases structure and activity and β-lactam antibiotics. Mini Rev. Med. Chem. 14, 111-122. doi: 10.2174/1389557514666140123145809
75. Raquet, X., Lamotte-Brasseur, J., Fonze, E., Goussard, S., Courvalin, P., and Frere, J. M. β. TEM beta-lactamase mutants hydrolysing third-generation cephalosporins-A kinetic and molecular modelling analysis. J. Mol. Biol. 244, 625-639. doi: 10.1006/jmbi.1994.1756
76. Raquet, X., Vanhove, M., Lamotte-Brasseur, J., Goussard, S., Courvalin, P., and Frere, J. M. (1995). Stability of TEM beta-lactamase mutants hydrolyzing third generation cephalosporins. Proteins 23, 63-72. doi: 10.1002/prot.340230108
77. Salverda, M. L. M., De Visser, J. A. G. M., and Barlow, M. (2010). Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance. FEMS Microbiol. Rev. 2010, 1-22. doi: 10.1111/j.1574-6976.2010.00222.x
78. Saves, I., Burlet-Schiltz, O., Maveyraud, L., Samama, J. P., Prome, J. C., and Masson, J. M. (1995). Mass spectral kinetic study of acylation and deacylation during hydrolysis of penicillins and ceftotaxime by β-lactamase TEM-1 and the G238S mutant. Biochemistry 34, 11660-11667. doi: 10.1021/bi00037a003
79. Shimamura, T., Ibuka, A., Fushinobu, S., Wakagi, T., Ishiguro, M., Ishii, Y., et al. (2002). Acyl-intermediate structures of the extended-spectrum class A β-lactamase, Toho-1, in complex with cefotaxime, cephalothin, and benzylpenicillin. J. Biol. Chem. 277, 46601-46608. doi: 10.1074/jbc. M207884200
80. Shortle, D., and Lin, B. (1985). Genetic analysis of Staphylococcal nuclease: identification of three intragenic "global suppressors" of nuclease minus mutations. Genetics 110, 539-555
81. Sideraki, V., Huang, W., Palzkill, T., and Gilbert, H. F. (2001). A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation. Proc. Natl. Acad. Sci. U.S.A. 98, 283-288. doi: 10.1073/pnas.011454198
82. Singh, M. K., and Dominy, B. N. (2012). The evolution of cefotaximase activity in the TEM-1 β-lactamase. J. Mol. Biol. 415, 205-220. doi: 10.1016/j.jmb.2011.10.041
83. Sowek, J. A., Singer, S. B., Ohringer, S., Malley, M. F., Dougherty, T. J., Gougoutas, J. Z., et al. (1991). Substitution of lysine at position 104 or 240 of TEM-1pTZ18R b-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam. Biochemistry 30, 3179-3188. doi: 10.1021/bi00227a004
84. Stemmer, W. (1994). Rapid evolution of a protein in vitro by DNA shuffling. Nature 370, 389-391. doi: 10.1038/370389a0
85. Stojanoski, V., Chow, D. C., Hu, L., Sankaran, B., Gilbert, H. F., Prasad, B. V., et al. (2015). A triple mutant in the O-loop of TEM-1 β-lactamase changes the substrate profile via a large conformational change and an altered general base for catalysis. J. Biol. Chem. 290, 10382-10394. doi: 10.1074/jbc. M114.633438
86. Strynadka, N. C. J., Adachi, H., Jensen, S. E., Johns, K., Sielecki, A., Betzel, C., et al. (1992). Molecular structure of the acyl-enzyme intermediate in β-lactam hydrolysis at 1.7 Å resolution. Nature 359, 700-705. doi: 10.1038/359700a0
87. Tokuriki, N., and Tawfik, D. S. (2009a). Protein dynamism and evolvability. Science 324, 203-207. doi: 10.1126/science.1169375
88. Tokuriki, N., and Tawfik, D. S. (2009b). Stability effects of mutations and protein evolvability. Curr. Opin. Struct. Biol. 19, 596-604. doi: 10.1016/j.sbi.2009.08.003
89. Vakulenko, S. B., Taibi-Tronche, P., Toth, M., Massova, I., Lerner, S. A., and Mobashery, S. (1999). Effects on substrate profile by mutational substitutions at positions 164 and 179 of the class A TEMpUC19 β-lactamase from Escherichia coli. J. Biol. Chem. 274, 23052-23060. doi: 10.1074/jbc.274.33.23052
90. Venkatachalam, K. V., Huang, W., Larocco, M., and Palzkill, T. (1994). Characterization of TEM-1 β-lactamase mutants from positions 238 to 241 with increased catalytic efficiency for ceftazidime. J. Biol. Chem. 269, 23444-23450
91. Viadiu, H., Osuna, J., Fink, A. L., and Soberon, X. (1995). A new TEM β-lactamase double mutant with broadened specificity reveals substrate-dependent functional interactions. J. Biol. Chem. 270, 781-787. doi: 10.1074/jbc.270.2.781
92. Wang, X., Minasov, G., and Shoichet, B. K. (2002). Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs. J. Mol. Biol. 320, 85-95. doi: 10.1016/S0022-2836(02)00400-X
93. Weinreich, D. M., Delaney, N. F., Depristo, M. A., and Hartl, D. L. (2006). Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312, 111-114. doi: 10.1126/science.1123539
94. Wells, J. A. (1990). Additivity of mutational effects in proteins. Biochemistry 29, 8509-8517. doi: 10.1021/bi00489a001
95. Yigit, H., Queenan, A. M., Rasheed, J. K., Biddle, J. W., Domenech-Sanchez, A., Alberti, S., et al. (2003). Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing β-lactamase KPC-2. Antimicrob. Agents Chemother. 47, 3881-3889. doi: 10.1128/AAC.47.12.3881-3889.2003
96. Zou, T., Risso, V. A., Gavira, J. A., Sanchez-Ruiz, J. M., and Ozkan, S. B. (2015). Evolution of conformational dynamics determines the conversion of a promiscuous generalist into a specialist enzyme. Mol. Biol. Evol. 32, 132-143. doi: 10.1093/molbev/msu281